Page last updated: 2024-10-30

loratadine and Anemia

loratadine has been researched along with Anemia in 1 studies

Loratadine: A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
loratadine : A benzocycloheptapyridine that is 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine substituted by a chloro group at position 8 and a 1-(ethoxycarbonyl)piperidin-4-ylidene group at position 11. It is a H1-receptor antagonist commonly employed in the treatment of allergic disorders.

Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.

Research Excerpts

ExcerptRelevanceReference
"Benserazide has been used chronically to inhibit amino acid decarboxylase to enhance plasma levels of L-dopa."1.42Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice. ( Boosalis, MS; Dai, Y; Faller, DV; Li, B; Makala, LH; Nouraie, M; Pace, BS; Perrine, SP; Sangerman, JI; Shen, L; White, E; White, GL; Wolf, RF, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boosalis, MS1
Sangerman, JI1
White, GL1
Wolf, RF1
Shen, L1
Dai, Y1
White, E1
Makala, LH1
Li, B1
Pace, BS1
Nouraie, M1
Faller, DV1
Perrine, SP1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 1b Sequential Open Label Dose-Ranging Study of Safety, Pharmacokinetics, and Preliminary Activity of Benserazide in Subjects With Beta Thalassemia Intermedia and Sickle Cell Disease[NCT04432623]Phase 1/Phase 236 participants (Anticipated)Interventional2020-10-05Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for loratadine and Anemia

ArticleYear
Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice.
    PloS one, 2015, Volume: 10, Issue:12

    Topics: Anemia; Animals; Benserazide; Drug Evaluation, Preclinical; Erythroid Precursor Cells; Fetal Hemoglo

2015